JPRN-jRCT2080225073已完成1 期
Pharmacokinetics in patients with hepatic dysfunction
Kyorin Pharmaceutical Co.,Ltd.0 个研究点目标入组 13 人开始时间: 2020年2月14日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 13
研究概览
简要总结
The pharmacokinetic parameters of KRP-AM1977X 75 mg were determined after single oral administration to patients with mild to moderate severity of hepatic dysfunction. The plasma drug concentration of AM-1977 in the moderate patients did not vary significantly compared with the mild patients. No major safety issues were identified in this study.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 80age old（—）
- 性别
- All
入选标准
- •Person with BMI that is more than 18.5 but less than 30.0, etc.
排除标准
- •Have a history of allergy or severe side effects to quinolone antibiotics.
研究者
相似试验
已完成
1 期
Phase I study of KRP-AM1977Y-JPRN-jRCT2080225244Kyorin Pharmaceutical Co., Ltd.18
已完成
1 期
Phase I study of KRP-AM1977X (Clinical pharmacological study)JPRN-jRCT2080225074Kyorin Pharmaceutical Co.,Ltd.23
已完成
1 期
Single-Dose Pharmacokinetics of BMS-790052 in Participants With Hepatic ImpairmentHepatic InsufficiencyNCT00859053Bristol-Myers Squibb46
终止
1 期
A Study to Evaluate the Pharmacokinetics of LY2624803 in Subjects With Hepatic ImpairmentInsomniaNCT01257178Eli Lilly and Company
已完成
1 期
A Pharmacokinetic Study of CKD-501 in Patients With Impaired Hepatic FunctionLiver DysfunctionNCT02005744Chong Kun Dang Pharmaceutical26